Rephonic
Artwork for Pharm to Table
Merck
Process Chemistry
Biocatalysis
Thiophene
Antibody-Drug Conjugates
Chemistry
Peptide Synthesis
Mk-0616
Organic Chemistry
Drug Discovery
Catalysis
Biocatalytic Cascades
Podcasting
Pharmaceutical Industry
Job Talks
On-Site Interviews
C-N Cross Coupling
Cyrene
Merck Chemistry
Pharmaceuticals

A podcast hosted by L.-C. Campeau and Dani Schultz that dives into the stories about the people behind the chemistry and science that happens at #MerckChemistry. Follow us on X (formerly Twitter) at @PharmToTablePod, @DrLCSquare, @danithechemist Email us comments and suggestions at pharmtotablepod@gmail.com

PublishesMonthlyEpisodes57Founded5 years ago
Number of ListenersCategories
ChemistryScience

Listen to this Podcast

Artwork for Pharm to Table

Latest Episodes

How do you design a manufacturing process for a molecule as complex as MK-0616? In Part 1 of this Pharm to Table series, Dani and LC join Stephanie Galanie, Director in Biocatalysis, and Artis Klapars, Distinguished Scientist in Process Chemistry, to... more

Part 1 laid out the strategy. Now, it’s time to make the molecule. Four enzymes, one vessel, and plenty of competing amines. What could possibly go wrong? Dani and LC return with Stephanie Galanie, Director in Biocatalysis, and Artis Klapars, Disting... more

Last episode, we watched medicinal chemistry dream up enclitide (MK-0616) — this week we find out what happens when someone actually has to make it. Dani and LC are joined by David Thaisrivongs and Gao Shang to unpack their recent JACS paper on the t... more

What happens when the textbook SAR playbook stops working? On this episode of Pharm to Table, Rob Garbaccio joins Dani and LC to share the discovery story behind enlicitide (MK-0616), a journey filled with unusual SAR, creative problem-solving, and p... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The Daily
The DailyThe New York Times
Economist Podcasts
Economist PodcastsThe Economist
Freakonomics Radio
Freakonomics RadioFreakonomics Radio + Stitcher
Acquired
AcquiredBen Gilbert and David Rosenthal
The Ezra Klein Show
The Ezra Klein ShowNew York Times Opinion

Recent Guests

Stephanie Galanie
Director in Biocatalysis
Merck
Episode: SE5:E5 - Part 2: Protecting Groups? We Need to Talk: Manufacturing MK-0616 with Enzyme Cascades
Artis Klapars
Distinguished Scientist in Process Chemistry
Merck
Episode: SE5:E5 - Part 2: Protecting Groups? We Need to Talk: Manufacturing MK-0616 with Enzyme Cascades
David Thaisrivongs
Head of the biocatalysis group at Merck
Merck
Episode: SE5:E3: A Process Chemist's Romance with Scaling a Macrocyclic Peptide
Gao Shang
Director in the small molecule process R&D group at Merck
Merck
Episode: SE5:E3: A Process Chemist's Romance with Scaling a Macrocyclic Peptide
Rob Garbaccio
Head of Medicinal Chemistry at Merck
Merck & Co.
Episode: SE5:E2: The Macrocyclic Mullet
Nastaran Salehi Marzijarani
Process Chemistry Lead at Merck, discussed as the guest who led the Oogie route preparation and de-risking
Merck
Episode: SE4:E8: From Discovery to Process, Part 2: Getting Ugi with it - scaling a 3CL protease inhibitor
Ben Turnbull
Process Chemistry Group member at Merck, discussed Yugi reaction optimization and endgame strategy
Merck
Episode: SE4:E8: From Discovery to Process, Part 2: Getting Ugi with it - scaling a 3CL protease inhibitor
Valerie Shurtleff
Medicinal chemist at Merck
Merck
Episode: SE4:E7: From Discovery to Process, Part 1: Building a 3CL Protease Inhibitor Through Smart Fluorine Placement and Design Intuition
Yining Ji Chen
Principal Scientist at Merck and recipient of the ACS Rising Star Award
Merck
Episode: SE4:E6 - Mechanism-Driven Innovation in Process Research: Yining Ji Chen’s Road as a Rising Star

Hosts

L.-C. Campeau
Chemist and science storyteller
Dani Schultz
Chemist and science communicator

Reviews

4.7 out of 5 stars from 40 ratings
  • I am lesser for having known this existed

    Corporate so called scientists raving about the chemical research capabilities of a publicly traded entity that only cares about profit and raising shareholder value as the bottom line. I cannot imagine using your own time to parrot such candy coated drivel while dragging in unwilling colleagues and academics desperate for industrial funding to repeat the party lines like some Soviet era propaganda piece. My heart goes out to the victims of this blatant self congratulatory affair. I can only ima... more

    Apple Podcasts
    1
    Unhook it
    United States4 months ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

One reviewer criticizes the corporate framing, describing the discussions as self-congratulatory and questioning their independence.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

SE5:E5 - Part 2: Protecting Groups? We Need to Talk: Manufacturing MK-0616 with Enzyme Cascades
Q: Why did we actually do this, evolving an enzyme on an analog rather than the actual substrate?
The team used a substrate walk, progressing from a native-like substrate through chemical analogs that gradually changed steric and electronic properties toward the desired reaction substrate.
SE5:E5 - Part 2: Protecting Groups? We Need to Talk: Manufacturing MK-0616 with Enzyme Cascades
Q: Can you walk us through why we need enzymes to make amide bonds?
Enzymes can avoid epimerization, selectively pair competing nucleophiles and electrophiles without protecting groups, and reduce unwanted oligomerization during macrocyclization.
SE5:E4 - Part 1: Protecting Groups? We Need to Talk: Manufacturing MK-0616 with Enzyme Cascades
Q: How do you even know where to start? Enlistetide is massive. Can you walk us through how you led the team in deciding what to work on very early on?
Klapars describes a retrosynthetic approach that breaks the molecule into large fragments at amide-bond junctions, prioritizing simplification, selectivity and avoiding protecting-group steps.
SE5:E4 - Part 1: Protecting Groups? We Need to Talk: Manufacturing MK-0616 with Enzyme Cascades
Q: Can you give our listeners a sense of the evolution of chemical routes over time, from Med-CAM through development and ultimately through commercial supply, and why this evolution is necessary?
Klapars says early project timelines often require a fit-for-purpose route, but commercialization calls for a better process that can lower costs, widen patient access and improve environmental sustainability.
SE4:E7: From Discovery to Process, Part 1: Building a 3CL Protease Inhibitor Through Smart Fluorine Placement and Design Intuition
Q: Why did you pick the 3CL protease as a potential target for drug discovery?
Valerie explained that the protease is critical to the viral replication cycle, highly conserved across coronaviruses, and its recognition sequence is distinct from human proteases, allowing for selectivity.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Pharm to Table

What is Pharm to Table about and what kind of topics does it cover?

Conversations with chemists and drug-development specialists trace how pharmaceutical research moves from early discovery to production at scale. Hosts L.-C. Campeau and Dani Schultz guide interviews that combine detailed technical discussion with career stories, team dynamics and reflections on the work behind medicines. Guests include medicinal and process chemists, research leaders and specialists in areas such as biocatalysis, peptide chemistry and catalytic methods. They explain decisions around molecular design, reaction development, safety, manufacturing and cross-disciplinary collaboration, often using specific drug-development projects to make complex chemistry tangible. The focus on Merck's research gives the discussions an indust... more

Where can I find podcast stats for Pharm to Table?

Rephonic provides a wide range of podcast stats for Pharm to Table. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Pharm to Table and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Pharm to Table get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Pharm to Table, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Pharm to Table?

Rephonic provides comprehensive predictive audience data for Pharm to Table, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Pharm to Table have?

To see how many followers or subscribers Pharm to Table has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Pharm to Table?

These podcasts share a similar audience with Pharm to Table:

1. The Daily
2. Economist Podcasts
3. Freakonomics Radio
4. Acquired
5. The Ezra Klein Show

How many episodes of Pharm to Table are there?

Pharm to Table launched 5 years ago and published 57 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Pharm to Table?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Pharm to Table?

Rephonic pulls ratings and reviews for Pharm to Table from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Pharm to Table?

Rephonic provides full transcripts for episodes of Pharm to Table. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Pharm to Table?

Recent guests on Pharm to Table include:

1. Stephanie Galanie
2. Artis Klapars
3. David Thaisrivongs
4. Gao Shang
5. Rob Garbaccio
6. Nastaran Salehi Marzijarani
7. Ben Turnbull
8. Valerie Shurtleff

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days